Serotonergic targets in depression

Current Opinion in Pharmacology

Volumn 2, Issue 1, 2002, Pages 18-22

  Middlemiss, Derek N ^a   Price, Gary W ^a   Watson, Jeannette M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 CARBAMOYLTRYPTAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PINDOLOL; RECEPTOR SUBTYPE; SB 269970; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 5A RECEPTOR; SEROTONIN 7 ANTAGONIST; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; SEROTONIN RECEPTOR;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG PENETRATION; DRUG SELECTIVITY; DRUG TARGETING; EXPERIMENTAL MODEL; GUINEA PIG; HIPPOCAMPUS; HUMAN; HYPOTHESIS; INDUCED HYPOTHERMIA; LATENT PERIOD; MEDICAL RESEARCH; MESOLIMBIC DOPAMINERGIC SYSTEM; METABOLISM; METHODOLOGY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHYSIOLOGY; RAT; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SLEEP DISORDER; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG DELIVERY SYSTEMS; HUMANS; RECEPTORS, SEROTONIN;

EID: 0036462443     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00116-3     Document Type: Review

References (50)

1. The biochemistry of affective disorders
2. Decreased plasma tryptophan concentration in major depression: Relationship to melancholia and weight loss
3. Tryptophan depletion causes a rapid lowering of mood in normal males
4. Enhancement of the antidepressant response to L-tryptophan by a liver pyrrolase inhibitor: A rational treatment
5. Pre- and postsynaptic effect of zimelidine and norzimelidine on the serotonergic system: Single cell studies in the rat
6. Current advances and trends in the treatment of depression
7. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat
8. 1A receptors: In vivo microdialysis and electrophysiological studies in rat brain
9. 1A receptors or β-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo
10. 1A receptor antagonist WAY100635
11. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
12. Pindolol augmentation of antidepressant therapy
13. 1A receptors in vivo and in vitro: Implications for antidepressant therapy
14. 11C] WAY100635
15. Fast adaptive changes of the sleep regulatory system after a single dose of the putative antidepressive substance EMD 68843
16. 1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective NAD-299 and NAS-181
17. 1A receptor activation and antidepressant-like effects: F13714 has high efficacy and marked antidepressant potential
18. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: Results from a placebo-controlled, randomized, double-blind, placebo wash-in study
19. 1A receptor control of dorsal raphe 5-HT neurones
20. 1A receptors control 5-HT release in the rat medial prefrontal cortex
21. 1A receptor antagonism
22. 1B receptor antagonist with negative intrinsic activity
23. 1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor
24. 1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig
25. 1 autoreceptors: Parallel purposes or pointless plurality
26. Interaction of serotonin autoreceptor antagonists in the rat dorsal raphe nucleus: An in vitro fast cyclic voltammetry study
27. 1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex
28. 1A or 5-HT re-uptake site blockade
29. 1B/D receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: The mechanism of action of (+)pindolol
30. 1D receptor antagonist in native tissue
31. 2A receptors mediate the effects of antidepressants in the elevated plus-maze test but have a partial role in the forced swim test
32. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder
33. Serotonergic antidepressants: Current and future perspectives
34. 2C receptor inverse agonist with improved anxiolytic profile: Lack of tolerance and withdrawal aniety
35. Receptor binding profile and anxiolytic-type activity of Deramciclane (EGIS-3886) in animal models
36. 2C receptor antagonist
37. Localization of serotonin 5A receptors in discrete regions of the circadian timing system in the syrian hamster
38. Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment
39. 7 receptors: Current knowledge and future prospects
40. 7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression
41. Serotogergic modulation of photic entrainment in the Syrian hamster
42. 7 receptor in rat brain
43. 7 receptors in the rodent suprachiasmatic nucleus
44. 7) implicated in the regulation of mammalian circadian rhythms
45. 7 receptor regulation in the rat hypothalamus
46. 7 receptor knockout in the mouse forced swim test
47. 7 antagonist: (R)-3-(2-(2-(4- methylpiperidin-1-Y1)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)
48. 7 receptor antagonist
49. A molecular and cellular theory of depression
50. 7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons